✦ LIBER ✦

Treatment of an acquired factor VIII inhibitor with sequential recombinant factor VIIa and FEIBA

✍ Scribed by G. G. MIRANDA; G. M. RODGERS

Book ID: 108773175
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 50 KB
Volume: 15
Category: Article
ISSN: 1351-8216
DOI: 10.1111/j.1365-2516.2008.01869.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effective treatment with recombinant fac

Effective treatment with recombinant factor VIIa of severe bleeding due to acquired factor VIII inhibitor and acquired thrombocytopathy

✍ Venancio Conesa; Angela Mompel; Francisco López; FRANCISCA Marín; José RUIZ; Fra 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB 👁 2 views

Treatment of factor XI inhibitor using r

Treatment of factor XI inhibitor using recombinant activated factor VIIa

✍ M. M. Bern; M. Sahud; O. Zhukov; K. Qu; W. Mitchell JR 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

Therapy-resistant haemarthros in a patie

Therapy-resistant haemarthros in a patient with factor VIII inhibitor: successful treatment with recombinant factor VIIa

✍ E. Lenz; M. Repas-Humpe; J. Oldenburg; W. Kreuz; W. Schröter; S. W. Eber 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 143 KB

Effects of factor VIII inhibitor bypassi

Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma

✍ T. LIVNAT; U. MARTINOWITZ; A. ZIVELIN; U. SELIGSOHN 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

Safety update on the use of recombinant

Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors

✍ T. ABSHIRE; G. KENET 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Successful treatment of acquired factor

Successful treatment of acquired factor VIII inhibitors with cyclosporin

✍ Brox, Alan G.; Laryea, Horace; Pelletier, Marc 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 11 KB 👁 2 views

The treatment of Factor VIII inhibitors remains controversial and no standard therapy exists. We describe in this report two consecutive patients with this inhibitor that responded to cyclosporin. Clinical improvement of the bleeding diathesis, a return to normal of the PTT, a decrease in the level